Benfluron hydrochloride
Benfluron hydrochloride is an Apoptosis inducer and inhibitor of the HIV-1 Rev-RRE complex, with an IC50 of 5.0 μM against the HIV-1 Rev-RRE complex. Benfluron hydrochloride induces p53 activation, and triggers phosphorylation of Chk1 at serine 345, Chk2 at threonine 68, as well as ERK1/2 at threonine 202 and tyrosine 204. Benfluron hydrochloride activates Caspase 8, Caspase 9 and Caspase 3/7, inhibits HIV-1 viral transcription, and acts as a substrate for 11β-HSD 1 and cytosolic carbonyl reductase. Benfluron hydrochloride can be used in research related to leukemia and HIV-1 infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 80427-58-3
- Formel: C21H20ClNO2
- Molecular Weight:353.84
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
ERK1 |
ERK2 |
Chk1 |
Chk2 |
Caspase-8 |
Caspase-9 |
Caspase 3 |
Caspase-7 |
HIV-1 |
In Vitro
Benfluron (0.2-1 μM; 24-72 h) hydrochloride reduces the proliferation capacity and viability of MOLT-4 cells in a concentration-dependent manner: cells are completely eliminated at concentrations of 0.8 μM and 1 μM after 48 h and 72 h; the cell viability is 49% at 0.6 μM after 48 h, and 33% at 0.6 μM after 72 h[1].
Benfluron (0.4-0.6 μM; 48 h) hydrochloride induces dose-dependent apoptosis in MOLT-4 cells, with the proportion of apoptotic cells reaching 26% at 0.4 μM and 81% at 0.6 μM after 48 h[1].
Benfluron (0.4-0.6 μM; 48 h) hydrochloride induces dose-dependent morphological changes associated with apoptosis in MOLT-4 cells. After 48 h, 25% of cells exhibit apoptotic light-scattering characteristics at the concentration of 0.4 μM, while this proportion reaches 73% at 0.6 μM[1].
Benfluron (0.4-0.6 μM; 24-48 h) hydrochloride induces dose-dependent activation of caspase 3/7, 8 and 9 in MOLT-4 cells, with significantly elevated activities observed at concentrations of 0.4, 0.5 and 0.6 μM after 24 h and 48 h[1].
Benfluron hydrochloride binds to HIV-1 RRE subdomain IIB with a Kd value of 4.83 µM[2].
Benfluron hydrochloride inhibits the formation of the full-length HIV-1 RRE-Rev complex, with an IC50 of 5.0 µM[2].
Benfluron hydrochloride potently inhibits HIV-1 replication in MT-2 cells, with an EC50 of 0.830 µM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human leukemic T lymphocyte MOLT-4 cells
-
Concentration:0.2-1 μM
-
Incubation Time:24, 48, 72 h
-
Result:Shows effect comparable to untreated control cells at 0.2 μM, increases percentage of dead cells to 16% after 72 h (vs. 5% in control) at 0.4 μM while total cell number still increases after 48 and 72 h, increases percentage of dead cells to 51% after 48 h and 67% after 72 h reducing viability to 49% and 33% respectively with almost complete inhibition of cell proliferation at 0.6 μM, and results in complete elimination of cells after 48 and 72 h at 0.8 μM and 1 μM.
-
Cell Line:human leukemic T lymphocyte MOLT-4 cells
-
Concentration:0.4-0.6 μM
-
Incubation Time:48 h
-
Result:Increases apoptotic cells to 26% (7% early apoptosis, 19% late apoptosis/death) at 0.4 μM (vs. 7% in control) and to 81% (14% early apoptosis, 67% late apoptosis/death) at 0.6 μM, an effect similar to the positive control mitoxantrone.\nIncreases population of cells with apoptotic light scatter properties to 25% at 0.4 μM (vs. 10% in control) and to 73% at 0.6 μM, consistent with Annexin V/PI staining results.
-
Cell Line:human leukemic T lymphocyte MOLT-4 cells
-
Concentration:0.4-0.6 μM
-
Incubation Time:16 h
-
Result:Results in 58% in G1 phase, 32% in S phase, and 10% in G2/M phase at 0.4 μM (vs. 62% G1, 31% S, 7% G2/M in control), and in 53% in G1 phase, 34% in S phase, and 13% in G2/M phase at 0.6 μM, showing dose-dependent accumulation in late S and G2/M phases.
Chemical Information
-
CAS. Nr. 80427-58-3
-
Molecular Weight 353.84
-
Formel C21H20ClNO2
-
SMILES
O=C1C2=C(C3=C1C=C(OCCN(C)C)C4=C3C=CC=C4)C=CC=C2.Cl
-
Synonyms
Benflurone hydrochloride
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Reinheit & Dokumentation
Verweise
[1]. Seifrtová M, et al. Benfluron Induces Cell Cycle Arrest, Apoptosis and Activation of p53 Pathway in MOLT-4 Leukemic Cells. Folia biologica. 2015;61(4):147-55. [Content Brief]
[2]. Chumillas S, et al. Exploring the HIV-1 Rev Recognition Element (RRE)-Rev Inhibitory Capacity and Antiretroviral Action of Benfluron Analogs. Molecules (Basel, Switzerland). 2023 Oct 11;28(20):7031. [Content Brief]
[3]. Skálová L, et al. Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro. Biochemical pharmacology. 2002 Jul 15;64(2):297-305. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)